These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY. Kronn D; Jansen V; Ostrer H Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684 [TBL] [Abstract][Full Text] [Related]
5. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. ACOG Committee on Genetics Obstet Gynecol; 2004 Aug; 104(2):425-8. PubMed ID: 15292027 [TBL] [Abstract][Full Text] [Related]
6. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease. Colaianni A; Chandrasekharan S; Cook-Deegan R Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311 [TBL] [Abstract][Full Text] [Related]
7. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews. DeMarchi JM; Caskey CT; Richards CS Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209 [TBL] [Abstract][Full Text] [Related]
8. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program. Rozenberg R; Pereira Lda V Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789 [TBL] [Abstract][Full Text] [Related]
9. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938 [TBL] [Abstract][Full Text] [Related]
10. ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol; 2009 Oct; 114(4):950. PubMed ID: 19888064 [TBL] [Abstract][Full Text] [Related]
12. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Hussein N; Henneman L; Kai J; Qureshi N Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010849. PubMed ID: 34634131 [TBL] [Abstract][Full Text] [Related]
13. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010849. PubMed ID: 29537064 [TBL] [Abstract][Full Text] [Related]
14. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated? Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947 [TBL] [Abstract][Full Text] [Related]
15. Carrier screening panels for Ashkenazi Jews: is more better? Leib JR; Gollust SE; Hull SC; Wilfond BS Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754 [TBL] [Abstract][Full Text] [Related]
16. Results of the College of American Pathology/American College of Medical Genetics and Genomics external proficiency testing from 2006 to 2013 for three conditions prevalent in the Ashkenazi Jewish population. Feldman GL; Schrijver I; Lyon E; Palomaki GE; Genet Med; 2014 Sep; 16(9):695-702. PubMed ID: 24577267 [TBL] [Abstract][Full Text] [Related]
18. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Mitchell JJ; Capua A; Clow C; Scriver CR Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593 [TBL] [Abstract][Full Text] [Related]
19. A re-examination of the use of ethnicity in prenatal carrier testing. Ross LF Am J Med Genet A; 2012 Jan; 158A(1):19-23. PubMed ID: 22106058 [TBL] [Abstract][Full Text] [Related]